Podcast: An investor’s guide to preparing your clinical data package
In recent years, the biotech financing landscape has been in a period of tumult, with ever-growing competition and shifts in…
30 Oct 2026
Prediction markets herald insider trading risks for private biotechs
The entry of prediction markets into the pharmaceutical sector means new pathways to access money, but also brings new risks. Prediction markets allow users to purchase a stake in the…
29 Oct 2026
Podcast: ESMO26: Major readouts from the 2026 congress
This year's European Society of Medical Oncology (ESMO) Congress has come to a close, with hundreds of studies having been presented. The congress, which took place in Madrid, Spain, from…
23 Oct 2026
Building the next generation of sustainable data centres in pharma
In the age of AI, pharma and tech companies are increasingly joining forces. Inevitably, such collaboration demands a strong digital infrastructure. Data centre construction has spiked drastically in recent years;…
22 Oct 2026
CPHI 2026: Pharma manufacturers put AI to work
Predictive maintenance, virtual process development, and artificial intelligence (AI)-assisted quality management are creating practical opportunities for pharmaceutical manufacturers. But the industry’s ability to scale these applications will depend less on…
22 Oct 2026
Podcast: The impact of prediction markets on the clinical sector
Publicly traded drug developers have been exposed to insider trading on their stocks for decades, but with the introduction of prediction markets in the clinical sector private companies are now…
12 Oct 2026
Women’s health landscape shifting, but systemic hurdles remain
It is no secret that research and development (R&D) efforts to improve care in women’s health have long been critically underfunded – with companies focused exclusively on women’s health attracting…